XML 103 R17.htm IDEA: XBRL DOCUMENT
v3.20.1

Shareholders' Equity | 12 Months Ended
--- | ---
Feb. 01, 2020
Shareholders' Equity [Abstract] |
Shareholders' Equity | 7. Shareholders' Equity Stock Compensation Plans Our Best Buy Co., Inc. Amended and Restated 2014 Omnibus Incentive Plan (the "Omnibus Plan") authorizes us to grant or issue non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock, restricted stock units and other equity awards up to a total of 22.5 million shares. We have not granted incentive stock options under the Omnibus Plan. Under the terms of the Omnibus Plan, awards may be granted to our employees, officers, advisers, consultants and directors. Awards issued under the Omnibus Plan vest as determined by the Compensation and Human Resources Committee of our Board of Directors at the time of grant. Awards granted, forfeited or canceled under the previous plan, the 2004 Omnibus Stock and Incentive Plan, after February 1, 2014, adjust the amount available under the Omnibus Plan. At February 1, 2020, a total of 9.4 million shares were available for future grants under the Omnibus Plan. Upon adoption and approval of the Omnibus Plan, all of our previous equity incentive compensation plans were terminated. However, existing awards under those plans continued to vest in accordance with the original vesting schedule and will expire at the end of their original terms. Our outstanding stock options have a 10-year term. Outstanding stock options issued to employees generally vest over a three year period. Share awards vest based either upon attainment of specified goals or solely upon continued employment ("time-based"). Outstanding share awards that are not time-based vest at the end of a three-year incentive period based upon our total shareholder return ("TSR") compared to the TSR of companies that comprise Standard & Poor's 500 Index ("market-based") or upon the achievement of company performance goals ("performance-based"). Generally, time-based share awards vest 33% on each of the three annual anniversary dates following the grant date. Time-based share awards to directors vest one year from the grant date. Stock-based compensation expense was as follows ($ in millions):
| 2020 |  | 2019 |  | 2018
Stock options | $ | 7 |  |  | $ | 3 |  |  | $ | 6 |
Share awards: |  |  |  |  |  |  |  |  |  |  |
Market-based |  | 13 |  |  |  | 15 |  |  |  | 19 |
Performance-based |  | 28 |  |  |  | 20 |  |  |  | 13 |
Time-based |  | 95 |  |  |  | 85 |  |  |  | 91 |
Total | $ | 143 |  |  | $ | 123 |  |  | $ | 129 |
Stock Options Stock option activity was as follows:
| Stock Options |  | Weighted-Average ‎Exercise Price per Share |  | Weighted-Average ‎Remaining Contractual Term (in years) |  | Aggregate ‎Intrinsic Value ‎(in millions)
Outstanding at February 2, 2019 | 2,358 |  |  | $ | 33.47 |  |  |  |  |  |  |  |  |
Granted | 719 |  |  | $ | 69.17 |  |  |  |  |  |  |  |  |
Exercised | (1,461) |  |  | $ | 27.92 |  |  |  |  |  |  |  |  |
Outstanding at February 1, 2020 | 1,616 |  |  | $ | 54.38 |  |  |  | 6.9 |  |  | $ | 49 |
Vested or expected to vest at February 1, 2020 | 1,616 |  |  | $ | 54.38 |  |  |  | 6.9 |  |  | $ | 49 |
Exercisable at February 1, 2020 | 712 |  |  | $ | 38.29 |  |  |  | 4.3 |  |  | $ | 33 |
The weighted-average grant-date fair value of stock options granted during fiscal 2020, fiscal 2019 and fiscal 2018 was $19.81, $20.34 and $12.52, respectively, per share. The aggregate intrinsic value of our stock options (the amount by which the market price of the stock on the date of exercise exceeded the exercise price of the option) exercised during fiscal 2020, fiscal 2019 and fiscal 2018, was $59 million, $33 million and $57 million, respectively. At February 1, 2020, there was $10 million of unrecognized compensation expense related to stock options that is expected to be recognized over a weighted-average period of 2.9 years. Net cash proceeds from the exercise of stock options were $40 million, $30 million and $156 million in fiscal 2020, fiscal 2019 and fiscal 2018, respectively. There was $14 million, $7 million and $19 million of income tax benefits realized from stock option exercises in fiscal 2020, fiscal 2019 and fiscal 2018, respectively. We estimated the fair value of each stock option on the date of grant using a lattice valuation model with the following assumptions:
Valuation Assumptions | 2020 |  | 2019 |  | 2018
Risk-free interest rate(1) | 1.9 | % | - | 2.5 | % |  | 1.9 | % | - | 2.8 | % |  | 0.9 | % | - | 2.6 | %
Expected dividend yield | 2.9 | % |  | 2.7 | % |  | 3.0 | %
Expected stock price volatility(2) | 36 | % |  | 39 | % |  | 38 | %
Expected life of stock options (in years)(3) | 7.4 |  |  | 6.5 |  |  | 6.0 |
(1)Based on the U.S. Treasury constant maturity interest rate whose term is consistent with the expected life of our stock options (2)In projecting expected stock price volatility, we consider both the historical volatility of our stock price as well as implied volatilities from exchange-traded options on our stock. (3)We estimate the expected life of stock options based upon historical experience. Market-Based Share Awards The fair value of market-based share awards is determined using Monte-Carlo simulation. A summary of the status of our non-vested market-based share awards was as follows (shares in millions):
Market-Based Share Awards | Shares |  | Weighted-Average Fair Value per Share
Outstanding at February 2, 2019 | 1,187 |  |  | $ | 40.07 |
Granted | 584 |  |  | $ | 72.90 |
Vested | (1,025) |  |  | $ | 29.90 |
Forfeited/canceled | (54) |  |  | $ | 58.96 |
Outstanding at February 1, 2020 | 692 |  |  | $ | 59.84 |
At February 1, 2020, there was $15 million of unrecognized compensation expense related to non-vested market-based share awards that we expect to recognize over a weighted-average period of 1.8 years. Time-Based Share Awards The fair value of time-based share awards is determined based on the closing market price of our stock on the date of grant. This value is reduced by the present value of expected dividends during vesting when the employee is not entitled to dividends. A summary of the status of our non-vested time-based share awards was as follows (shares in millions):
Time-Based Share Awards | Shares |  | Weighted-Average Fair Value per Share
Outstanding at February 2, 2019 | 4,098 |  |  | $ | 47.13 |
Granted | 1,880 |  |  | $ | 68.80 |
Vested | (1,868) |  |  | $ | 45.01 |
Forfeited/canceled | (258) |  |  | $ | 62.23 |
Outstanding at February 1, 2020 | 3,852 |  |  | $ | 57.81 |
At February 1, 2020, there was $116 million of unrecognized compensation expense related to non-vested time-based share awards that we expect to recognize over a weighted-average period of 1.8 years. Performance-Based Share Awards The fair value of performance-based share awards is determined based on the closing market price of our stock on the date of grant. This value is reduced by the present value of expected dividends during vesting when the employee is not entitled to dividends. A summary of the status of our non-vested performance-based share awards was as follows (shares in millions):
Performance-Based Share Awards | Shares |  | Weighted-Average Fair Value per Share
Outstanding at February 2, 2019 | 819 |  |  | $ | 52.78 |
Granted | 516 |  |  | $ | 68.90 |
Vested | (274) |  |  | $ | 42.08 |
Forfeited/canceled | (108) |  |  | $ | 59.80 |
Outstanding at February 1, 2020 | 953 |  |  | $ | 63.82 |
At February 1, 2020, there was $30 million of unrecognized compensation expense related to non-vested performance-based share awards that we expect to recognize over a weighted-average period of 1.8 years. Earnings per Share We compute our basic earnings per share based on the weighted-average number of common shares outstanding, and our diluted earnings per share based on the weighted-average number of common shares outstanding adjusted by the number of additional shares that would have been outstanding had the potentially dilutive common shares been issued. Potentially dilutive securities include stock options and non-vested share awards. Non-vested market-based share awards and non-vested performance-based share awards are included in the average diluted shares outstanding each period if established market or performance criteria have been met at the end of the respective periods. At February 1, 2020, options to purchase common stock were all in the money and outstanding as follows (shares in millions):
| Exercisable |  | Unexercisable |  | Total
| Shares |  | % |  | Weighted- ‎Average Price ‎per Share |  | Shares |  | % |  | Weighted- ‎Average Price ‎per Share |  | Shares |  | % |  | Weighted- ‎Average Price ‎per Share
In-the-money | 0.7 |  |  | 100 | % |  | $ | 38.29 |  |  | 0.9 |  |  | 100 | % |  | $ | 67.04 |  |  | 1.6 |  |  | 100 | % |  | $ | 54.38 |
Reconciliations of the numerators and denominators of basic and diluted earnings per share from continuing operations were as follows ($ and shares in millions, except per share amounts):
| 2020 |  | 2019 |  | 2018
Numerator |  |  |  |  |  |  |  |  |  |  |
Net earnings from continuing operations | $ | 1,541 |  |  | $ | 1,464 |  |  | $ | 999 |
Denominator |  |  |  |  |  |  |  |  |  |  |
Weighted-average common shares outstanding |  | 264.9 |  |  |  | 276.4 |  |  |  | 300.4 |
Effect of potentially dilutive securities: |  |  |  |  |  |  |  |  |  |  |
Stock options and other |  | 3.2 |  |  |  | 5.0 |  |  |  | 6.7 |
Weighted-average common shares outstanding, assuming dilution |  | 268.1 |  |  |  | 281.4 |  |  |  | 307.1 |
Anti-dilutive securities excluded from Weighted-average common shares outstanding, assuming dilution |  | 0.8 |  |  |  | 0.2 |  |  |  | - |
Net earnings per share from continuing operations |  |  |  |  |  |  |  |  |  |  |
Basic | $ | 5.82 |  |  | $ | 5.30 |  |  | $ | 3.33 |
Diluted | $ | 5.75 |  |  | $ | 5.20 |  |  | $ | 3.26 |
Repurchase of Common Stock On February 23, 2019, our Board of Directors authorized a $3.0 billion share repurchase program. There is no expiration date governing the period over which we can repurchase shares under this authorization. Information regarding the shares we repurchased and retired was as follows ($ and shares in millions, except per share amounts):
| 2020 |  | 2019 |  | 2018
Total cost of shares repurchased | $ | 1,009 |  |  | $ | 1,493 |  |  | $ | 2,009 |
Average price per share | $ | 72.34 |  |  | $ | 70.28 |  |  | $ | 57.16 |
Number of shares repurchased and retired |  | 14.0 |  |  |  | 21.2 |  |  |  | 35.1 |
Between the end of fiscal 2020 on February 1, 2020, and March 18, 2020, we repurchased an incremental 0.6 million shares of our common stock at a cost of $56 million. We have since temporarily suspended all share repurchases. Repurchased shares have been retired and constitute authorized but unissued shares.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration